Specialized in the development of orphan drugs.

MendeliKABS’s vision is to expand access to orphan drugs in order to effectively meet the needs of patients worldwide.

Supported by a proven cGMP compliant infrastructure, the rapid development, manufacturing and distribution of orphan drugs is our priority.

Inspired by the principle that people with rare diseases should be offered affordable drug solutions, universal access to effective medication is at the heart of our work.